Lista de obras -

126 novel mutations in Italian patients with neurofibromatosis type 1.

artículo científico publicado en 2015

A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.

artículo científico publicado en 2014

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

artículo científico publicado en 2016

Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival

artículo científico publicado en 2015

Association of chromosome 10 losses and negative prognosis in oligoastrocytomas.

artículo científico publicado en 2002

Biopsy-proven primary angiitis of the central nervous system mimicking leukodystrophy: A case report and review of the literature

artículo científico publicado en 2019

CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients.

artículo científico publicado en 2005

CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells.

artículo científico publicado en 2004

Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease).

artículo científico publicado en 2012

Characterization of 22q12 Microdeletions Causing Position Effect in Rare NF2 Patients with Complex Phenotypes

scientific article published in 2022

Cisplatinum and BCNU chemotherapy in primary glioblastoma patients.

artículo científico publicado en 2009

Clonal evolution of glioblastoma under therapy.

artículo científico publicado en 2016

Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study.

artículo científico publicado en 2005

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

artículo científico publicado en 2015

Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis.

artículo científico publicado en 2017

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

artículo científico publicado en 2017

Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumours.

artículo científico publicado en 2001

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma

scientific article published on 04 July 2019

Erratum to: Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature

correction of a scholarly article

Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types.

artículo científico publicado en 2004

Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature

artículo científico

FABP4 is a candidate marker of cerebellar liponeurocytomas.

artículo científico publicado en 2012

Fluorescein-Guided Surgery for Resection of High-Grade Gliomas: A Multicentric Prospective Phase II Study (FLUOGLIO).

artículo científico publicado en 2017

Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases ⬇️

artículo científico publicado el 10 de mayo de 2013

Fluorescein-guided surgery for malignant gliomas: a review.

artículo científico publicado en 2014

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.

artículo científico publicado en 2013

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.

artículo científico publicado en 2017

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

artículo científico publicado en 2015

Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma.

artículo científico publicado en 2005

Is fluorescein-guided technique able to help in resection of high-grade gliomas?

artículo científico publicado en 2014

Lupus anticoagulants and antiphospholipid antibodies monitoring in systemic lupus erythematosus

artículo científico publicado el 1 de enero de 1992

Management of epilepsy in brain tumors

artículo científico publicado en 2019

Meningo-cortical calcifying angiomatosis and celiac disease.

artículo científico publicado en 1998

Molecular markers of gliomas: a clinical approach.

artículo científico publicado en 2006

Neurological malignancies in neurofibromatosis type 1

scientific article published on 01 November 2019

Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients

scientific article published on 05 November 2019

Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48.

artículo científico publicado en 2014

Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan.

artículo científico publicado en 2014

Phosphorylated Acetyl-CoA Carboxylase is associated with clinical benefit with Regorafenib in relapsed glioblastoma: REGOMA Trial Biomarker Analysis

artículo científico publicado en 2020

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).

artículo científico publicado en 2015

Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan

artículo científico publicado en 2013

Reclassification of oligoastrocytomas by loss of heterozygosity studies.

artículo científico publicado en 2006

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.

artículo científico publicado en 2018

Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors.

artículo científico publicado en 1999

Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.

artículo científico publicado en 2007

Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients

artículo científico publicado en 2020

Stroke-like events after brain radiotherapy: a large series with long-term follow-up

scientific article published on 10 January 2019

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide

artículo científico publicado en 2018

Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas.

artículo científico publicado en 2009

Systemic temozolomide combined with loco-regional mitoxantrone in treating recurrent glioblastoma.

artículo científico publicado en 2005

The molecular landscape of glioma in patients with Neurofibromatosis 1

artículo científico publicado en 2018

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates.

artículo científico publicado en 2013

The noncoding RNA AK127244 in 2p16.3 locus: A new susceptibility region for neuropsychiatric disorders

artículo científico publicado en 2018

Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?

artículo científico publicado en 2008

VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.

artículo científico publicado en 2014

Venous thromboembolism in malignant glioma patients treated by chemoradiotherapy.

artículo científico publicado en 2003

Lista de obras de

126 novel mutations in Italian patients with neurofibromatosis type 1.

A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival

Association of chromosome 10 losses and negative prognosis in oligoastrocytomas.

Biopsy-proven primary angiitis of the central nervous system mimicking leukodystrophy: A case report and review of the literature

CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients.

CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells.

Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease).

Characterization of 22q12 Microdeletions Causing Position Effect in Rare NF2 Patients with Complex Phenotypes

Cisplatinum and BCNU chemotherapy in primary glioblastoma patients.

Clonal evolution of glioblastoma under therapy.

Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study.

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis.

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumours.

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma

Erratum to: Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature

Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types.

Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature

FABP4 is a candidate marker of cerebellar liponeurocytomas.

Fluorescein-Guided Surgery for Resection of High-Grade Gliomas: A Multicentric Prospective Phase II Study (FLUOGLIO).

Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases ⬇️

Fluorescein-guided surgery for malignant gliomas: a review.

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma.

Is fluorescein-guided technique able to help in resection of high-grade gliomas?

Lupus anticoagulants and antiphospholipid antibodies monitoring in systemic lupus erythematosus

Management of epilepsy in brain tumors

Meningo-cortical calcifying angiomatosis and celiac disease.

Molecular markers of gliomas: a clinical approach.

Neurological malignancies in neurofibromatosis type 1

Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients

Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48.

Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan.

Phosphorylated Acetyl-CoA Carboxylase is associated with clinical benefit with Regorafenib in relapsed glioblastoma: REGOMA Trial Biomarker Analysis

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).

Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan

Reclassification of oligoastrocytomas by loss of heterozygosity studies.

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.

Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors.

Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.

Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients

Stroke-like events after brain radiotherapy: a large series with long-term follow-up

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide

Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas.

Systemic temozolomide combined with loco-regional mitoxantrone in treating recurrent glioblastoma.

The molecular landscape of glioma in patients with Neurofibromatosis 1

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates.

The noncoding RNA AK127244 in 2p16.3 locus: A new susceptibility region for neuropsychiatric disorders

Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?

VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.

Venous thromboembolism in malignant glioma patients treated by chemoradiotherapy.